Coherus BioSciences, Inc. (CHRS)

Coherus BioSciences Revenue

Coherus BioSciences had revenue of $301.87M in the twelve months ending March 31, 2024, with 64.63% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $77.06M with 137.58% year-over-year growth. In the year 2023, Coherus BioSciences had annual revenue of $257.24M with 21.89% growth.

• Revenue (ttm): $301.87M
• Revenue Growth: +64.63%
• P/S Ratio: 0.62
• Revenue / Employee: $986,507
• Employees: 306
• Market Cap: 188.15M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	257.24M	46.20M	21.89%
Dec 31, 2022	211.04M	-115.51M	-35.37%
Dec 31, 2021	326.55M	-149.27M	-31.37%
Dec 31, 2020	475.82M	119.75M	33.63%
Dec 31, 2019	356.07M	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	1.56M	-188.55M	-99.18%
Dec 31, 2016	190.11M	160.07M	532.82%
Dec 31, 2015	30.04M	-1.07M	-3.42%
Dec 31, 2014	31.11M	28.36M	1,030.72%
Dec 31, 2013	2.75M	852.00K	44.87%
Dec 31, 2012	1.90M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.